Description
The National Institutes of Health (NIH) intends to negotiate with GraphPad Software, LLC, for the renewal of GraphPad Prism software licenses. GraphPad Prism is a powerful software package used in scientific research, particularly in biostatistics, pharmacology, and life sciences. It offers an intuitive interface, streamlines the data analysis process, and provides customizable templates for data visualization. The software is proprietary, and the government has a significant financial investment in it. The NIH is seeking to renew the licenses due to the software's versatility and reliability in enhancing the efficiency and quality of data analysis.
Key features of the software include:
• User-friendly interface
• Intuitive data analysis process
• Customizable templates for data visualization
• Efficient data organization and management
• Ability to integrate with other statistical software and tools
• Extensive documentation and support
The NIH is seeking a firm-fixed-price contract, and the estimated value of the acquisition is $39,000.00.